BiochemProbe — Life Science Research Reagents

Brimarafenib free base

Brimarafenib is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor wtih antineoplastic effect .

For research use only. Not for human or veterinary use.

Target Raf
Research area Cancer
Purity >98% Stock Inquire

Brimarafenib structure

CAS No.: 1643326-82-2

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 989.00 BP-00331-50mg In stock Get quote
100 mg USD 1,580.00 BP-00331-100mg In stock Get quote
250 mg USD 2,680.00 BP-00331-250mg In stock Get quote

Description

Brimarafenib is a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor wtih antineoplastic effect .

Specifications

MW (average)
482.4114
Formula
C24H17F3N4O4
CAS No.
1643326-82-2
Physical state
Solid
Color
White to off-white
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 3 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

In vitro
DMSO : 33.33 mg/mL

References

[1]. Brimarafenibum (Brimarafenib). WHO Drug Information, Vol. 37, No. 4, 2023.

Same target

Search Raf

Same research area

Search Cancer